The filing

Please find enclosed rating rationale issued by India Ratings and Research

Company

Glenmark Pharmaceuticals Ltd · BSE 532296

Filed

11 September 2026, 08:45 IST

BSE category

Company Update / Credit Rating

Tag

Credit Rating · selected

Source

Open the filing on BSE →

Why it led

• First Credit Rating from this company — not seen in the 73 trading days on record
• Mid cap · NIFTY 500
• 2 filings today

Selected by the ranker from 40 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

785 of 88,170 filings in the published window carry Credit Rating · 0.89%

Around it

Also filed by Glenmark Pharmaceuticals Ltd on 11 September 2026

• Shareholder Meeting / Postal Ballot-Scrutinizer's Report AGM / EGM
• Shareholder Meeting / Postal Ballot-Outcome of AGM AGM / EGM
• Press Release / Media Release Press Release

Most recent filings from Glenmark Pharmaceuticals Ltd

• Shareholder Meeting / Postal Ballot-Scrutinizer's Report AGM / EGM 11 September 2026
• Shareholder Meeting / Postal Ballot-Outcome of AGM AGM / EGM 11 September 2026
• Press Release / Media Release Press Release 11 September 2026